Article
Cost-benefit analysis of serological and nucleic acid testing for hepatitis B virus in blood donors in southern China
2 Sept 2024
Abstract excerpt
BACKGROUND: Most Chinese blood centers have implemented mini pool (MP) HBV nucleic acid testing (NAT) together with HBsAg ELISA in routine blood donor screening for HBV infection since 2015, and a few centers upgraded MP to individual donation (ID) NAT screening recently, raising urgent need for cost-benefit analysis of different screening strategies. In an effort to prevent transfusion-transmitted infections...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
